Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPsychiatry/Behavioral HealthAetna phototherapy coverage & prior auth | OpenPay…
    Ask Trek AI about this page
    CurrentAetnaPolicy 0370

    Phototherapy for Psychiatric Disorders

    Customize your policy alerts

    Sign up for Aetna Policy 0370 alerts

    Get alerted when Policy 0370 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Aetna's coverage stance for high-intensity light box therapy (DME) for seasonal affective disorder (SAD) and lists procedures/indications considered experimental/investigational. Applies to members seeking phototherapy for psychiatric indications.

    Policy Summary
    PayerAetna
    PolicyPhototherapy for Psychiatric Disorders
    Policy CodePolicy 0370
    Change TypeNo material change noted
    Effective DateJan 31, 2000
    Last ReviewJun 6, 2023
    Next Review DateApr 11, 2024
    Key ActionObtain prior authorization for therapeutic lightbox (HCPCS E0203) as DME when selection criteria for SAD are met.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    10,000 luxtherapeutic intensity
    2 yearsrequired seasonal duration
    1 monthrental trial period
    11+experimental indications listed
    06/06/2023last review
    04/11/2024next review

    Coverage Criteria for Phototherapy

    Medical Necessity for high-intensity light unit (DME)

    Covered when ALL of the following are met:

    SAD DME coverage criteria: 1) Member is diagnosed with bipolar disorder or recurrent major depression; AND 2) Member meets DSM‑V criteria for a seasonal mood disorder: at least 2 years of seasonal depressive episodes which completely remit when daylight increases in the spring and which substantially outnumber any non‑seasonal depressive episodes.at least 2 years of seasonal depressive episodes

    When criteria are met, rental of the high‑intensity light unit is covered for the first month to assess effectiveness.

    Experimental and Investigational

    Considered experimental and investigational (not an all-inclusive list) for the following:

    Experimental/Investigational list - light box therapy indications: Light box therapy for depressive symptoms in persons with any of: anorexia nervosa; childhood sleep disorders; cystic fibrosis; non‑seasonal depression; Parkinson disease; post‑natal depression; pre‑menstrual syndrome; sleep disorders in the elderly and in visually impaired children; sleep or behavioral disorders in dementia; type 2 diabetes.

    Effectiveness not established.

    Experimental - extra‑ocular light therapy: Extra‑ocular light therapy (application of phototherapy to areas of the body other than the retina) for all indications including treatment of members with SAD.

    Effectiveness not established.

    Experimental - non‑retinal photo‑biomodulation: Non‑retinal photo‑biomodulation with red and near‑infrared light (low‑level light therapy) for the treatment of depressive disorder.

    Effectiveness not established.

    Light box therapy and bright light therapy are considered experimental and investigational for a range of non‑SAD indications because effectiveness has not been established. Specifically, the policy lists light box therapy for depressive symptoms in persons with anorexia nervosa; childhood sleep disorders; cystic fibrosis; non‑seasonal depression; Parkinson disease; post‑natal depression; pre‑menstrual syndrome; sleep disorders in the elderly and in visually impaired children; sleep or behavioral disorders in dementia; and type 2 diabetes as investigational. The policy also states that extra‑ocular light therapy (phototherapy applied to body areas other than the retina) and non‑retinal photobiomodulation with red and near‑infrared light are considered investigational for all indications.

    A 2022 meta‑analysis of blue‑wavelength light therapy found no evidence of superiority of blue light versus inactive or active control conditions for seasonal or non‑seasonal major depressive disorder. The authors concluded that the effectiveness of blue‑light therapy for both seasonal and non‑seasonal MDD remains unproven, citing small sample sizes, short treatment durations, variable light parameters across studies, and heterogeneity as key limitations that require larger, longer, and better‑standardized trials.

    This Clinical Policy Bulletin is provided to assist in administering plan benefits and does not constitute an offer of coverage or medical advice. It contains only a partial, general description of plan or program benefits and is not a contract. Treating providers remain solely responsible for medical care and outcomes. The bulletin may be updated and is subject to change.

    Bright light therapy is not established / not medically necessary for many non‑SAD indications due to insufficient or inconsistent evidence. Systematic reviews and evidence summaries have failed to identify reliable support for use of light therapy in post‑natal depression, pre‑menstrual syndrome, non‑seasonal depression, sleep disorders in children or the elderly, and sleep or behavioral disorders in dementia. The policy therefore treats these and other listed conditions as investigational or not medically necessary unless new, high‑quality evidence demonstrates benefit.

    In a double‑blind, controlled trial of patients with Parkinson disease and MDD, bright light therapy (approximately 10,000 lux) was not superior to a control light (approximately 200 lux) in reducing depressive symptoms. Although mood and subjective sleep improved in both groups and BLT improved subjective sleep quality more than control light, the primary outcome showed no between‑group benefit for BLT, providing Class I evidence of no superiority over control light in this population.

    Coding and Code Status

    Covered CPT Codes (as referenced)CPT
    96900Actinotherapy (ultraviolet light).
    Covered HCPCS CodesHCPCSCovered
    E0203Therapeutic lightbox, minimum 10,000 lux, table top model.
    A4634Replacement bulb for therapeutic light box, tabletop model.
    ICD-10 Codes covered when selection criteria metICD-10Covered
    F30.10 - F32.9Bipolar disorder [seasonal affective disorder].
    F33.0 - F33.9Major depressive disorder, recurrent [seasonal affective disorder].
    ICD-10 Codes not covered / experimental indications listedICD-10Not Covered
    F02.80 - F02.818Dementia in other diseases classified elsewhere with or without behavioral disturbance.
    F03.90 - F03.918Unspecified dementia.
    F05Delirium due to known physiological condition.
    F50.00 - F50.02Anorexia nervosa.
    F51.01 - F51.9Sleep disorders not due to a substance or known physiological condition.
    F53.0 - F53.1Mental and behavioral disorders associated with the puerperium, not elsewhere classified.
    G47.00 - G47.39Sleep disorders.
    G47.50 - G47.9Sleep disorders.
    G47.14Hypersomnia with sleep apnea, unspecified.
    H53.001 - H53.9Visual disturbances.
    1–10 of 17
    1/2
    Covered CPT Codesmixed
    No codes listed
    Therapeutic light intensity — minimum 10,000 lux
    Minimum therapeutic intensity10,000 lux
    Associated HCPCS codeE0203 — Therapeutic lightbox, minimum 10,000 lux, table top model
    Device classificationDurable medical equipment (DME) for home phototherapy
    PurposeProvides bright light exposure for treatment of seasonal affective disorder (SAD)

    Provider Actions, Authorization & Billing

    Prior Authorization

    Prior authorization required for therapeutic lightbox (DME)

    Aetna requires prior authorization for a high-intensity therapeutic lightbox (DME) when the selection criteria for seasonal affective disorder (SAD) are met; e.g., HCPCS E0203 (therapeutic lightbox, minimum 10,000 lux).

    • Prior authorization applies when member meets DSM‑V seasonal mood disorder criteria and diagnosis requirements.
    Prior Authorization

    No additional explicit prior authorization rules in evidence sections

    These sections of the document provide evidence summaries and references but do not state additional explicit prior authorization rules or list other CPT/HCPCS codes requiring authorization.

    • Chunks referenced are background/evidence and do not specify administrative prior authorization rules.

    Phototherapy and Related Modalities

    Bright Light Therapy (BLT / light box)

    Bright Light Therapy for SAD: Use of bright light therapy is established for seasonal affective disorder; may be considered as initial treatment comparable to antidepressants and in combination with CBT based on randomized trials demonstrating comparable or improved outcomes.

    Evidence supports effectiveness for SAD; when selection criteria are met Aetna covers rental of a high-intensity light unit for the first month to assess home phototherapy.

    phototherapy (bright light, blue light, dawn simulation, transcranial PBM)

    dawn simulation: Dawn simulation produced similar median depression score reductions to conventional bright light in a crossover study of winter depression; patient preference varied.

    Alternative to conventional bright light for SAD; effectiveness similar in small trials.

    transcranial photobiomodulation (t-PBM):

    Definitions

    High-intensity light unit / therapeutic lightbox
    DefinitionHigh-intensity light unit (therapeutic lightbox): durable medical equipment delivering therapeutic bright light for home phototherapy
    Minimum intensityApproximately 10,000 lux (minimum) — required for therapeutic effect
    Billing codesHCPCS E0203 (therapeutic lightbox, min 10,000 lux); A4634 (replacement bulb)
    Coverage noteWhen medical necessity criteria for SAD are met, rental of the high-intensity light unit is covered for the first month to assess effectiveness
    transcranial photobiomodulation (t-PBM) / PBM
    DefinitionTranscranial photobiomodulation (t-PBM) / PBM: use of red and/or near-infrared light (non-retinal exposure) delivered transcranially or intra-nasally intended to boost cerebral mitochondrial metabolism and promote neuroplasticity

    Background

    Seasonal affective disorder (SAD) is a cyclic, light‑related form of major depression that typically occurs in the darker months and remits with increased daylight. Bright light therapy (using a high‑intensity light unit delivering a therapeutic bright light) is an established treatment for SAD when specific clinical criteria are met: the member must have bipolar disorder or recurrent major depression and meet DSM‑V criteria for a seasonal mood disorder with at least 2 years of seasonal depressive episodes that remit in spring and substantially outnumber non‑seasonal episodes. When criteria are met, rental of a high‑intensity light unit (therapeutic lightbox) is covered for the first month to assess effectiveness.

    Policy History & References

    Step Therapy

    References/administrative sections: no step therapy specified

    Reference and administrative sections confirm no step therapy requirements are specified in the policy.

    Note

    Policy history and administrative notes (no new provider actions)

    Administrative notes list policy review dates and history but do not change provider action requirements.

    Policy Summary
    PayerAetna
    PolicyPhototherapy for Psychiatric Disorders
    Policy CodePolicy 0370
    Change TypeNo material change noted
    Effective DateJan 31, 2000
    Last ReviewJun 6, 2023
    Next Review DateApr 11, 2024
    Key ActionObtain prior authorization for therapeutic lightbox (HCPCS E0203) as DME when selection criteria for SAD are met.
    SourceLink
    On This Page
    Coverage Criteria for PhototherapyCoding and Code StatusProvider Actions, Authorization & BillingPhototherapy and Related ModalitiesDefinitionsBackgroundPolicy History & References
    Prior Authorization

    No other explicit prior authorization requirements in administrative excerpts

    The policy excerpts provided (administrative/history sections) do not describe any additional explicit prior authorization requirements beyond the DME/lightbox rule above.

    • Policy history and administrative notes are present, but authorization specifics are not contained in these chunks.
    Step Therapy

    No step therapy requirements specified

    The policy does not specify any step therapy requirements for phototherapy; no sequencing or required trials of other therapies are mandated in the lightbox coverage criteria.

    • Step therapy field in the policy is listed as “None specified.”
    Step Therapy

    CBT‑I is first‑line for insomnia; light therapy not established as first‑line

    For insomnia the referenced guideline recommends cognitive behavioral therapy for insomnia (CBT‑I) as first‑line; light therapy and exercise are noted as needing further evaluation rather than being first‑line monotherapies.

    • CBT‑I is recommended as 1st‑line treatment for chronic insomnia in adults (strong recommendation).
    • Pharmacologic therapy may be offered if CBT‑I is ineffective or unavailable; light therapy is not presented as first‑line.
    Step Therapy

    No step therapy requirements in references/administrative sections

    Reference and administrative sections do not impose step therapy requirements for phototherapy; no mandated trial of other agents or therapies is specified prior to coverage of the high‑intensity light unit when SAD criteria are met.

    • The listed reference chunks contain citations and background but do not define step therapy sequencing.
    Documentation Required

    Required clinical documentation to support SAD and device

    Clinical documentation submitted must support a DSM‑V diagnosis of bipolar disorder or recurrent major depression and demonstrate a seasonal pattern of at least 2 years (seasonal depressive episodes that remit in spring and substantially outnumber non‑seasonal episodes).

    • When criteria are met, documentation should also indicate the device prescribed or rented (e.g., therapeutic lightbox, minimum 10,000 lux).
    • Rental of the high‑intensity light unit is covered for the first month to assess effectiveness when criteria are met.
    Documentation Required

    Clinical workup documentation required for insomnia evaluation

    For insomnia assessments, clinical workup documentation should include a sleep history (habits, environment, schedules, circadian factors), use of sleep questionnaires and diaries, review of somatic and mental health, physical exam and additional tests if indicated; polysomnography is indicated when other sleep disorders are suspected or in treatment‑resistant cases.

    • Polysomnography is recommended for suspected other sleep disorders, treatment‑resistant insomnia, professional at‑risk populations, or substantial sleep state misperception.
    Note

    Administrative/policy history notes — no additional provider documentation actions

    The provided administrative and history sections contain policy history and references but do not add further specific provider documentation actions beyond the clinical documentation requirements already stated.

    • Administrative notes clarify the CPB is not a contract and may be updated; they do not specify additional authorization documentation requirements.
    Denial Risk

    Denial risk if selection/coverage criteria not met for E0203/A4634/96900

    Claims for therapeutic lightbox (HCPCS E0203), replacement bulbs (A4634), or actinotherapy (CPT 96900) may be denied if the selection/coverage criteria for SAD are not met or if used for indications listed as experimental/investigational.

    • Experimental/investigational indications include non‑seasonal depression, Parkinson disease, post‑natal depression, anorexia nervosa, dementia‑related sleep/behavioral disorders, and others listed in the policy.
    • Denial risk applies when documentation does not support the DSM‑V seasonal pattern or required diagnosis.
    Note

    Reference sections do not define additional authorization or denial triggers

    Some evidence/reference sections included in the document are background only and do not state explicit administrative authorization or billing denial triggers.

    • Use these reference sections for clinical context; they do not change the explicit prior authorization or denial rules stated elsewhere in the policy.
    Denial Risk

    No new denial triggers in policy history/administrative excerpts

    The policy history and administrative excerpts do not provide explicit denial triggers beyond those tied to unmet selection/coverage criteria; they list review dates and administrative notes.

    • Policy history entries and additional information clarify the document’s scope but do not add authorization rules.
    Pilot double-blind sham-controlled studies show medium-to-large effect sizes for adjunctive t-PBM in major depressive disorder but are limited by small sample sizes and require replication.

    Promising but insufficient evidence for routine coverage.

    blue-wavelength light therapy (BWLT): Moderate-quality evidence suggests BWLT may reduce depression and fatigue after traumatic brain injury, but trials are few and small; meta-analyses in non-seasonal depression found no consistent benefit.

    Evidence mixed; not established for broader non-seasonal depression indications.

    bright light therapy (BLT) for bipolar and other non-SAD indications: BLT evidence is mixed for bipolar depression and Parkinson disease depression; some sensitivity analyses suggest benefit but overall meta-analyses often show no significant difference versus control and further well-designed studies are needed.

    Clinical findings vary by condition and modality; safety signals in pilots showed no serious AEs but sample sizes small.

    MechanismNIR/red light absorbed by mitochondria (cytochrome C oxidase) to enhance cerebral metabolism, modulate opioids, and reduce inflammation/oxidative stress
    Clinical statusInvestigational for treatment of depressive disorder (effectiveness not established); preliminary studies show medium-to-large effect sizes but require replication
    Typical parameters (reported in pilot study)Example: 823-nm NIR, continuous wave, 20–30 min/session, twice-weekly for 8 weeks (pilot study specifics)
    dawn simulation
    DefinitionDawn simulation: gradually increasing light delivered during the last portion of sleep to mimic sunrise (e.g., achieving ~100 lx before awakening, with additional exposure up to ~250 lx)
    Clinical comparisonIn crossover trials dawn simulation produced similar reductions in depression scores as conventional bright light therapy for winter depression
    Patient preferencePreference varied by individual; some prefer dawn simulation for perceived naturalness or convenience, while more severely depressed patients tended to prefer bright light
    Use caseConsidered an alternative modality to conventional bright light therapy for seasonal affective disorder (SAD)